FOXA1 and chronic kidney disease: Our general aim was to provide novel insights into the role of HNF3α in the molecular pathogenesis of renal fibrosis, and thereby lay the groundwork for new targeted therapeutic interventions that mitigate or reverse the progression of renal fibrosis and CKD.